Om V Singh

Summary

Affiliation: Johns Hopkins University
Country: USA

Publications

  1. ncbi Biotechnological production of gluconic acid: future implications
    Om V Singh
    Department of Pediatrics, The Johns Hopkins School of Medicine, 600 N Wolfe St, CMSC, 3 106, Baltimore, MD 21287, USA
    Appl Microbiol Biotechnol 75:713-22. 2007
  2. ncbi Genetically modified crops: success, safety assessment, and public concern
    Om V Singh
    Department of Pediatrics, The John Hopkins School of Medicine, Baltimore, MD 21287, USA
    Appl Microbiol Biotechnol 71:598-607. 2006
  3. ncbi Proteomics and metabolomics: the molecular make-up of toxic aromatic pollutant bioremediation
    Om V Singh
    Department of Pediatrics, The Johns Hopkins School of Medicine, Baltimore, MD, USA
    Proteomics 6:5481-92. 2006
  4. ncbi Transcriptomics, proteomics and interactomics: unique approaches to track the insights of bioremediation
    Om V Singh
    Department of Pediatrics, The Johns Hopkins School of Medicine, Baltimore, MD 21287, USA
    Brief Funct Genomic Proteomic 4:355-62. 2006
  5. ncbi Applications of proteomic technologies for understanding the premature proteolysis of CFTR
    Mark J Henderson
    Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, MD 21287, USA
    Expert Rev Proteomics 7:473-86. 2010
  6. ncbi Proteome of synaptosome-associated proteins in spinal cord dorsal horn after peripheral nerve injury
    Om V Singh
    Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
    Proteomics 9:1241-53. 2009
  7. ncbi High-dimensional biology to comprehend hepatocellular carcinoma
    Perumal Vivekanandan
    Department of Pathology, Baltimore, MD 21287, USA
    Expert Rev Proteomics 5:45-60. 2008
  8. ncbi Chemical rescue of deltaF508-CFTR mimics genetic repair in cystic fibrosis bronchial epithelial cells
    Om V Singh
    Department of Pediatrics, The Johns Hopkins School of Medicine, Baltimore, Maryland 21287, USA
    Mol Cell Proteomics 7:1099-110. 2008
  9. ncbi Pharmacoproteomics of 4-phenylbutyrate-treated IB3-1 cystic fibrosis bronchial epithelial cells
    Om V Singh
    Department of Pediatrics, The Johns Hopkins School of Medicine, Baltimore, Maryland 21209, USA
    J Proteome Res 5:562-71. 2006
  10. ncbi Bioconversion of lignocellulosic biomass: biochemical and molecular perspectives
    Raj Kumar
    Radiation Biotechnology Unit, Division of Radiation Biology and Radiation Protection, Institute of Nuclear Medicine and Allied Sciences, New Delhi, 110054 India
    J Ind Microbiol Biotechnol 35:377-91. 2008

Detail Information

Publications12

  1. ncbi Biotechnological production of gluconic acid: future implications
    Om V Singh
    Department of Pediatrics, The Johns Hopkins School of Medicine, 600 N Wolfe St, CMSC, 3 106, Baltimore, MD 21287, USA
    Appl Microbiol Biotechnol 75:713-22. 2007
    ..8%, and banana must may assist reducing the overall cost of GA production. These methodologies would open new markets and increase applications of GA...
  2. ncbi Genetically modified crops: success, safety assessment, and public concern
    Om V Singh
    Department of Pediatrics, The John Hopkins School of Medicine, Baltimore, MD 21287, USA
    Appl Microbiol Biotechnol 71:598-607. 2006
    ..We feel that it is important to establish an internationally harmonized framework for the safe handling of recombinant DNA organisms within a few years...
  3. ncbi Proteomics and metabolomics: the molecular make-up of toxic aromatic pollutant bioremediation
    Om V Singh
    Department of Pediatrics, The Johns Hopkins School of Medicine, Baltimore, MD, USA
    Proteomics 6:5481-92. 2006
    ..This article deals with advances in environmental proteomics and metabolomics and advocates the simultaneous study of both technologies to implement cell-free bioremediation...
  4. ncbi Transcriptomics, proteomics and interactomics: unique approaches to track the insights of bioremediation
    Om V Singh
    Department of Pediatrics, The Johns Hopkins School of Medicine, Baltimore, MD 21287, USA
    Brief Funct Genomic Proteomic 4:355-62. 2006
    ..Exploring the differential expression of a wide variety of proteins and screening of the entire genome for proteins that interact with particular mineralization regulatory factors would help us to gain insights into bioremediation...
  5. ncbi Applications of proteomic technologies for understanding the premature proteolysis of CFTR
    Mark J Henderson
    Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, MD 21287, USA
    Expert Rev Proteomics 7:473-86. 2010
    ..Additionally, we emphasize the potential for proteomic-based technologies in expanding our understanding of CF pathophysiology and therapeutic approaches...
  6. ncbi Proteome of synaptosome-associated proteins in spinal cord dorsal horn after peripheral nerve injury
    Om V Singh
    Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
    Proteomics 9:1241-53. 2009
    ..These changes might participate in the central mechanism that underlies the maintenance of neuropathic pain...
  7. ncbi High-dimensional biology to comprehend hepatocellular carcinoma
    Perumal Vivekanandan
    Department of Pathology, Baltimore, MD 21287, USA
    Expert Rev Proteomics 5:45-60. 2008
    ..With the extensive use of HDB, it may be possible in the near future, to have custom-made therapeutic regimens for HCC based on the molecular subtype, ultimately leading to an improved survival of HCC patients...
  8. ncbi Chemical rescue of deltaF508-CFTR mimics genetic repair in cystic fibrosis bronchial epithelial cells
    Om V Singh
    Department of Pediatrics, The Johns Hopkins School of Medicine, Baltimore, Maryland 21287, USA
    Mol Cell Proteomics 7:1099-110. 2008
    ..We conclude that chemically rescued CFTR associates with a specific set of HSP70 family proteins that mark therapeutic interactions and can be useful to correct both ion transport and inflammatory phenotypes in CF subjects...
  9. ncbi Pharmacoproteomics of 4-phenylbutyrate-treated IB3-1 cystic fibrosis bronchial epithelial cells
    Om V Singh
    Department of Pediatrics, The Johns Hopkins School of Medicine, Baltimore, Maryland 21209, USA
    J Proteome Res 5:562-71. 2006
    ..Subsets of these proteins were confirmed by immunoblot analysis. These data represent a first-draft of the pharmacoproteomics map of 4-PBA treated cystic fibrosis bronchial epithelial cells...
  10. ncbi Bioconversion of lignocellulosic biomass: biochemical and molecular perspectives
    Raj Kumar
    Radiation Biotechnology Unit, Division of Radiation Biology and Radiation Protection, Institute of Nuclear Medicine and Allied Sciences, New Delhi, 110054 India
    J Ind Microbiol Biotechnol 35:377-91. 2008
    ....
  11. ncbi Bioremediation of radionuclides: emerging technologies
    Raj Kumar
    Division of Radiation Biology and Radiation Protection, Institute of Nuclear Medicine and Allied Sciences, New Delhi 100 054, India
    OMICS 11:295-304. 2007
    ..transcriptomics and proteomics. Studies combining functional transcriptomics and proteomics would create a system-wide approach studying the microbial metabolism in radionuclides detoxification...
  12. ncbi Polycyclic aromatic hydrocarbons: environmental pollution and bioremediation
    Sudip K Samanta
    Institute of Microbial Technology, Sector-39A, 160036, Chandigarh, India
    Trends Biotechnol 20:243-8. 2002
    ..Chemotaxis could also have an important role in enhancing biodegradation of pollutants. Here, we discuss the problems of PAH pollution and PAH degradation, and relevant bioremediation efforts...